Dynavax Technologies
DVAX
$11.20
Share price
1.08%
Change (1 day)
-5.56%
Change (1 year)
Categories
Dynavax Technologies (DVAX) - Cash on Hand
Cash on Hand as of March 2023 : $0.65 B
According to Dynavax Technologies
's latest financial reports the company has $0.65 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Dynavax Technologies - Cash on Hand chart (from 2003 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.62 B | 14.37% |
| 2021-12-31 | $0.54 B | 230.81% |
| 2020-12-31 | $0.16 B | 9.26% |
| 2019-12-31 | $0.15 B | 3.79% |
| 2018-12-31 | $0.14 B | -24.14% |
| 2017-12-31 | $0.19 B | 135.65% |
| 2016-12-31 | $81.41 M | -58.49% |
| 2015-12-31 | $0.19 B | 59.9% |
| 2014-12-31 | $0.12 B | -35.23% |
| 2013-12-31 | $0.18 B | 51.34% |
| 2012-12-31 | $0.12 B | 9.8% |
| 2011-12-31 | $0.11 B | 57.94% |
| 2010-12-31 | $72.15 M | 96.5% |
| 2009-12-31 | $36.72 M | -46.38% |
| 2008-12-31 | $68.47 M | 20.95% |
| 2007-12-31 | $56.61 M | -22.26% |
| 2006-12-31 | $72.83 M | -3.03% |
| 2005-12-31 | $75.11 M | 14.07% |
| 2004-12-31 | $65.84 M | 126.29% |
| 2003-12-31 | $29.09 M | -1.06% |
| 2002-12-31 | $29.41 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $22.73 B | 3,386.74% | 🇺🇸 USA |
 Amgen AMGN | $31.56 B | 4,740.97% | 🇺🇸 USA |
 Biogen BIIB | $5.04 B | 673.26% | 🇺🇸 USA |
 Gilead Sciences GILD | $7.20 B | 1,004.37% | 🇺🇸 USA |
 Merck MRK | $13.19 B | 1,923.45% | 🇺🇸 USA |
 AstraZeneca AZN | $6.46 B | 891.17% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $8.64 B | 1,225.26% | 🇬🇧 UK |
 Agenus
AGEN | $0.19 B | -70.34% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $2.80 B | 329.63% | 🇮🇱 Israel |